Prostate cancer is the most common cancer in men in the US with a lifetime risk
of 16.7%. This cancer is the third most common cancer seen at St. Anthonys (SAH)
accounting for 13 % of all cases in the Cancer Registry, and for 28% of all cancers in
men. We reviewed 1,570 analytic cases in the
registry from 1987 through the end of 2002 and present the data here with appropriate
comparisons with national data (the NCI SEER data and the NCDB or national cancer data
base). |
Stage |
Number |
Age |
Survival |
National |
0 |
14 (1%) |
71.5y |
100% |
100% |
Local |
1156 (74%) |
73y |
100% |
100% |
Regional |
265 (17%) |
71y |
100% |
100% |
Distant |
92 (6%) |
78y |
30% |
34% |
Stage |
Number |
Percent |
Age |
Survival/5y (SAH) |
Survival/5y |
0 |
96 |
6% |
76y |
99% |
88% |
I |
259 |
16% |
75y |
100% |
92% |
II |
716 |
46% |
71y |
100% |
91% |
III |
187 |
12% |
70y |
100% |
91% |
IV |
132 |
8% |
75y |
55% |
48% |
Treatment with radical prostatectomy increased in the early 90s commensurate with the increased incidence of early stage disease and has leveled off at about 30% of all patients and is primarily used in younger men. It is difficult to make outcome comparison between surgery or radiation but both forms of treatment appear to have excellent results based on survival. (PSA control rates are considered a better measure of outcome but complete data was not available on enough patients to make this comparison.) |